文献速递慢性肾脏病血液净化与透析水电解质与酸碱

透析起始时甲状旁腺激素水平决定后续继发性甲旁亢控制风险

The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

基于21国5683例新发血液透析患者的前瞻性队列研究,按透析起始前即刻测定的甲状旁腺激素(PTH)分层,评估起始后第一年活性维生素D和拟钙剂使用及9-12个月PTH>600 pg/mL的风险。起始前PTH>600 pg/mL者占16%,其9-12个月PTH>600 pg/mL的患病率为29%,显著高于起始PTH 150-300 pg/mL者的7%(调整风险差19%,95%CI 15%-23%)。

要点

  • 透析起始前PTH>600 pg/mL者占16%,后续PTH控制更差。
  • 起始PTH>600者9-12个月PTH>600风险较150-300者高19%。
  • 尽管活性维生素D和拟钙剂使用更多,高PTH仍持续。

核心结论

  • 透析起始前PTH升高预测9-12个月后PTH水平更高,尽管活性维生素D和拟钙剂使用更多。

研究设计与样本

  • 透析预后与实践模式研究(DOPPS)第4-6期(2009-18)前瞻性队列,纳入21国5683例新发血液透析患者。

主要发现

  • 起始前PTH>600 pg/mL者占16%,第一年活性维生素D和拟钙剂处方更普遍。
  • 起始PTH>600 pg/mL者9-12个月PTH>600 pg/mL患病率为29%,起始PTH 150-300 pg/mL者为7%。
  • 调整风险差为19%(95%CI 15%-23%)。
  • 9-12个月持续PTH>600 pg/mL者更年轻、黑人比例更高、透析起始时血磷和eGFR更高。

临床怎么用

  • 非透析慢性肾脏病期间应更积极控制PTH,可能影响透析后结局。
  • 提示需要制定非透析CKD患者的PTH目标指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Optimal parathyroid hormone (PTH) control during non-dialysis chronic kidney disease (ND-CKD) might decrease the subsequent risk of parathyroid hyperplasia and uncontrolled secondary hyperparathyroidism (SHPT) on dialysis. However, the evidence for recommending PTH targets and therapeutic strategies is weak for ND-CKD. We evaluated the patient characteristics, treatment patterns and PTH control over the first year of haemodialysis (HD) by PTH prior to HD initiation. METHODS: We studied 5683 incident HD patients from 21 countries in Dialysis Outcomes and Practice Patterns Study Phases 4-6 (2009-18). We stratified by PTH measured immediately prior to HD initiation and reported the monthly prescription prevalence of active vitamin D and calcimimetics over the first year of HD and risk of PTH >600 pg/mL after 9-12 months on HD. RESULTS: The 16% of patients with PTH >600 pg/mL prior to HD initiation were more likely to be prescribed active vitamin D and calcimimetics during the first year of HD. The prevalence of PTH >600 pg/mL 9-12 months after start of HD was greater for patients who initiated HD with PTH >600 (29%) versus 150-300 (7%) pg/mL (adjusted risk difference: 19%; 95% confidence interval : 15%, 23%). The patients with sustained PTH >600 pg/mL after 9-12 months on HD were younger, more likely to be black, and had higher serum phosphorus and estimated glomerular filtration rates at HD initiation. CONCLUSIONS: Increased PTH before HD start predicted a higher PTH level 9-12 months later, despite greater use of active vitamin D and calcimimetics. More targeted PTH control during ND-CKD may influence outcomes during HD, raising the need for PTH target guidelines in these patients.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Tabibzadeh N, Karaboyas A, Robinson BM, et al. The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation. Nephrol Dial Transplant. 2021. PMID: 33068419. doi:10.1093/ndt/gfaa195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。